Prognostic visualization model for primary pulmonary sarcoma: a SEER-based study.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
18 10 2023
18 10 2023
Historique:
received:
17
03
2023
accepted:
15
10
2023
medline:
23
10
2023
pubmed:
19
10
2023
entrez:
18
10
2023
Statut:
epublish
Résumé
Primary pulmonary sarcoma (PPS) is a rare and poor prognostic malignancy that results from current clinical studies are lacking. Our study aimed to investigate the prognostic factors of PPS and to construct a predictive nomogram that predict the overall survival (OS) rate. We extracted data on patients diagnosed with PPS from 2010 to 2019 in the SEER database. A total of 169 patients were included after screening by inclusion and exclusion criteria. Univariate and multivariate COX regression analyses showed that age, pathological grade, liver metastasis, surgical intervention, and chemotherapy influenced the prognosis. We constructed the prediction model nomogram based on these factors. Moreover, the results of the internal and external ROC curves, calibration curves, and DCA plots confirmed that the model has good discrimination, accuracy, and clinical practice efficacy. The present study is the first population-based study to explore the factors affecting the prognosis of PPS. We established a novel prognostic nomogram to predict the OS rate, which can help to make proper clinical decisions.
Identifiants
pubmed: 37853232
doi: 10.1038/s41598-023-45058-7
pii: 10.1038/s41598-023-45058-7
pmc: PMC10584923
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17774Informations de copyright
© 2023. Springer Nature Limited.
Références
Régnard, J. F. et al. Prognostic factors and results after surgical treatment of primary sarcomas of the lung. Ann. Thorac. Surg. 68(1), 227–231. https://doi.org/10.1016/s0003-4975(99)00398-7 (1999).
doi: 10.1016/s0003-4975(99)00398-7
pubmed: 10421146
Guccion, J. G. & Rosen, S. H. Bronchopulmonary leiomyosarcoma and fibrosarcoma. A study of 32 cases and review of the literature. Cancer 30(3), 836–847 (1972).
doi: 10.1002/1097-0142(197209)30:3<836::AID-CNCR2820300335>3.0.CO;2-C
pubmed: 5075364
Porte, H. L. et al. Surgical treatment of primary sarcoma of the lung. Eur. J. Cardiothorac. Surg. 18(2), 136–142. https://doi.org/10.1016/s1010-7940(00)00465-6 (2000).
doi: 10.1016/s1010-7940(00)00465-6
pubmed: 10925220
Petrov, D. B. et al. Primary pulmonary sarcomas and carcinosarcomas–postoperative results and comparative survival analysis. Eur. J. Cardiothorac. Surg. 23(4), 461–466. https://doi.org/10.1016/s1010-7940(03)00024-1 (2003).
doi: 10.1016/s1010-7940(03)00024-1
pubmed: 12694760
Robinson, L. A. et al. Results of treating primary pulmonary sarcomas and pulmonary carcinosarcomas. J. Thorac. Cardiovasc. Surg. 162(1), 274–284. https://doi.org/10.1016/j.jtcvs.2020.03.179 (2021).
doi: 10.1016/j.jtcvs.2020.03.179
pubmed: 32711968
Spraker, M. B. et al. An analysis of patient characteristics and clinical outcomes in primary pulmonary sarcoma. J. Thorac. Oncol. 8(2), 147–151. https://doi.org/10.1097/JTO.0b013e318277401f (2013).
doi: 10.1097/JTO.0b013e318277401f
pubmed: 23263688
Yin, K. et al. Clinical features and surgical outcomes of pulmonary artery sarcoma. J. Thorac. Cardiovasc. Surg. 155(3), 1109-1115.e1. https://doi.org/10.1016/j.jtcvs.2017.10.101 (2018).
doi: 10.1016/j.jtcvs.2017.10.101
pubmed: 29223846
Berzenji, L. & Van Schil, P. E. Commentary: Primary pulmonary sarcomas and pulmonary carcinosarcomas, challenging and enigmatic, but treatable!. J. Thorac. Cardiovasc. Surg. 162(1), 286–287. https://doi.org/10.1016/j.jtcvs.2020.03.138 (2021).
doi: 10.1016/j.jtcvs.2020.03.138
pubmed: 32386767
Yeo, S. G. Primary lung sarcoma treated with stereotactic ablative radiotherapy: A case report. Onco Targets Ther. 10, 3285–3288. https://doi.org/10.2147/OTT.S138595 (2017).
doi: 10.2147/OTT.S138595
pubmed: 28740403
pmcid: 5505615
Collaud, S. et al. Multimodality treatment including surgery for primary pulmonary sarcoma: Size does matter. J. Surg. Oncol. 122(3), 506–514. https://doi.org/10.1002/jso.25979 (2020).
doi: 10.1002/jso.25979
pubmed: 32410271
Tavora, F., Miettinen, M., Fanburg-Smith, J., Franks, T. J. & Burke, A. Pulmonary artery sarcoma: A histologic and follow-up study with emphasis on a subset of low-grade myofibroblastic sarcomas with a good long-term follow-up. Am. J. Surg. Pathol. 32(12), 1751–1761. https://doi.org/10.1097/PAS.0b013e31817d7fd0 (2008).
doi: 10.1097/PAS.0b013e31817d7fd0
pubmed: 18779732
Etienne-Mastroianni, B. et al. Primary sarcomas of the lung: A clinicopathologic study of 12 cases. Lung Cancer. 38(3), 283–289. https://doi.org/10.1016/s0169-5002(02)00303-3 (2002).
doi: 10.1016/s0169-5002(02)00303-3
pubmed: 12445750
Balachandran, V. P., Gonen, M., Smith, J. J. & DeMatteo, R. P. Nomograms in oncology: More than meets the eye. Lancet Oncol. 16(4), e173–e180. https://doi.org/10.1016/S1470-2045(14)71116-7 (2015).
doi: 10.1016/S1470-2045(14)71116-7
pubmed: 25846097
pmcid: 4465353
Jia, J. & Chen, W. Role of radiation therapy in primary tonsil large B cell lymphoma: A SEER-based analysis. Radiat. Oncol. 16(1), 193. https://doi.org/10.1186/s13014-021-01919-x (2021).
doi: 10.1186/s13014-021-01919-x
pubmed: 34600539
pmcid: 8487472
Janssen, J. P., Mulder, J. J., Wagenaar, S. S., Elbers, H. R. & van den Bosch, J. M. Primary sarcoma of the lung: A clinical study with long-term follow-up. Ann. Thorac. Surg. 58(4), 1151–1155. https://doi.org/10.1016/0003-4975(94)90476-6 (1994).
doi: 10.1016/0003-4975(94)90476-6
pubmed: 7944769
Attanoos, R. L., Appleton, M. A. & Gibbs, A. R. Primary sarcomas of the lung: A clinicopathological and immunohistochemical study of 14 cases. Histopathology 29(1), 29–36. https://doi.org/10.1046/j.1365-2559.1996.d01-481.x (1996).
doi: 10.1046/j.1365-2559.1996.d01-481.x
pubmed: 8818691
Bacha, E. A. et al. Surgical treatment of primary pulmonary sarcomas. Eur. J. Cardiothorac. Surg. 15(4), 456–460. https://doi.org/10.1016/s1010-7940(99)00045-7 (1999).
doi: 10.1016/s1010-7940(99)00045-7
pubmed: 10371121
Muscolino, G., Bedini, A. V. & Buffa, P. F. Leiomyosarcoma of the bronchus: Report of two cases of resection with long-term follow-up. J. Thorac. Cardiovasc. Surg. 119(4 Pt 1), 853–854. https://doi.org/10.1016/S0022-5223(00)70025-0 (2000).
doi: 10.1016/S0022-5223(00)70025-0
pubmed: 10733781
Magné, N. et al. Primary lung sarcomas: Long survivors obtained with iterative complete surgery. Lung Cancer 31(2–3), 241–245. https://doi.org/10.1016/s0169-5002(00)00167-7 (2001).
doi: 10.1016/s0169-5002(00)00167-7
pubmed: 11165403
Steuer, C. E. et al. Pulmonary sarcomatoid carcinoma: An analysis of the national cancer data base. Clin. Lung Cancer 18(3), 286–292. https://doi.org/10.1016/j.cllc.2016.11.016 (2017).
doi: 10.1016/j.cllc.2016.11.016
pubmed: 28043773
Li, A. X. et al. Outcomes of surgically managed primary lung sarcomas: A national cancer database analysis. J. Thorac. Dis. 13(6), 3409–3419 (2021).
doi: 10.21037/jtd-21-1
pubmed: 34277037
pmcid: 8264694
Liang, L., Liu, Z., Wang, C. & Xie, S. Adjuvant chemotherapy is not a decisive factor in improving the overall survival of pulmonary sarcoma: A population-based study. Front. Oncol. 12, 940839. https://doi.org/10.3389/fonc.2022.940839 (2022).
doi: 10.3389/fonc.2022.940839
pubmed: 36091171
pmcid: 9452885
Vieira, T. et al. Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma. J. Thorac. Oncol. 8(12), 1574–1577. https://doi.org/10.1097/01.JTO.0000437008.00554.90 (2013).
doi: 10.1097/01.JTO.0000437008.00554.90
pubmed: 24389441
Hong, J. Y. et al. The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma. Med. Oncol. 26(3), 287–291. https://doi.org/10.1007/s12032-008-9117-4 (2009).
doi: 10.1007/s12032-008-9117-4
pubmed: 18989796
Lee, J. et al. Efficacy of mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) in patients with advanced pulmonary pleomorphic carcinoma. Lung Cancer. 122, 160–164. https://doi.org/10.1016/j.lungcan.2018.06.009 (2018).
doi: 10.1016/j.lungcan.2018.06.009
pubmed: 30032825